About Neptune Biotech Private Limited
Data last updated:
Neptune Biotech Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 2013.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U36912DL2013PTC260166. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹19 Lakh and a paid-up capital of ₹15 Lakh. It was led by directors including Nitya Nand Karna and Punam Karna.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Shop No. – 206 Plot No. – 6 Sector – 12 Vardhman Bahnof Plaza Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2018, the company reported a revenue of ₹90.25 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.47 Lakh (net margin 1.6%) and EBITDA of ₹6.27 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
Court records list 7 cases involving the company, including 7 filed against it; 2 cases are pending.
The last known website on record is neptunebiotechltd.com.
Company details
Contact details
Neptune Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is neptunebiotechltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShop No. – 206 Plot No. – 6 Sector – 12 Vardhman Bahnof Plaza Dwarka, New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neptune Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neptune Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Neptune Biotech Private Limited, buy the company report.
Financials of Neptune Biotech Private Limited
FY 2018 filings availableNeptune Biotech Private Limited reported revenue of ₹90.25 Lakh (up 5% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 81% over three years, including 5% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.27 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.47 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 1.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Neptune Biotech Private Limited, buy the company report.
Board of directors of Neptune Biotech Private Limited
Neptune Biotech has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Karn | Additional Director | 14 Mar 2016 | 10 Years 7 Months | As last reported |
| Ram Ratan Chaudhary | Additional Director | 14 Mar 2016 | 10 Years 7 Months | As last reported |
| Nitya Nand Karna Also directs: Chitragupta Travels Private Limited | Director | 12 Nov 2013 | 12 Years 11 Months | As last reported |
| Punam Karna Also directs: Chitragupta Travels Private Limited | Director | 12 Nov 2013 | 12 Years 11 Months | As last reported |
Auditor
Neptune Biotech Private Limited is audited by VINAY SINHA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINAY SINHA & CO | FY 2017 | 016634N |
Shareholding
The shareholding of Neptune Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Neptune Biotech Private Limited, buy the company report.
Legal cases
Neptune Biotech Private Limited has 7 court cases on record: 7 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 2 |
Cases on record (4 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by M/S HDFC Bank Ltd. | Pending |
| District court, Etawah, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| District court, Bijnor, Uttar Pradesh | Criminal case | Filed against the company by an individual | Disposed |
| District court, East, Delhi | Court case (OMP (I)(COMM.)) | Filed against the company by Tata Motors Fin. Ltd. | Disposed |
To see the full case history of Neptune Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neptune Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neptune Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Neptune Biotech Private Limited, buy the company report.
Recent activity
Neptune Biotech Private Limited has 4 board changes on record since 2013: 4 appointments. The latest: Narendra Karn was appointed as Additional Director on 14 Mar 2016.
Frequently asked questions
Neptune Biotech has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Neptune Biotech was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 12 November 2013 and is registered under CIN U36912DL2013PTC260166. The company has been struck off by the Registrar of Companies and is no longer operational.
Neptune Biotech had 4 directors:
- Narendra Karn - Additional Director
- Ram Ratan Chaudhary - Additional Director
- Nitya Nand Karna - Director
- Punam Karna - Director
The CIN (Corporate Identification Number) of Neptune Biotech is U36912DL2013PTC260166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Neptune Biotech is at Shop No. – 206 Plot No. – 6 Sector – 12 Vardhman Bahnof Plaza Dwarka, New Delhi, Delhi, India – 110075.
Neptune Biotech was incorporated on 12 November 2013. It is registered with the Registrar of Companies, Delhi.
Neptune Biotech can be reached through the website neptunebiotechltd.com. Its registered office is in New Delhi, Delhi, India.
The latest financial statements of Neptune Biotech on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Neptune Biotech has 1 GST registration on record and it is cancelled or inactive.
Neptune Biotech operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
